ArticleMedical science monitor : international medical journal of experimental and clinical research2026
Patterns of miRNA Expression in Primary and Metastatic Wilms Tumor.
Article in Medical science monitor : international medical journal of experimental and clinical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Wilms tumor (WT) development and the ability to form distant metastases are thought to be governed by a wide range of molecular factors, with prominent involvement of microRNAs (miRNAs). However, very few studies have explored alterations in miRNA expression between primary and metastatic WT, and all of them focused on a narrow set of miRNAs. MATERIAL AND METHODS We investigated miRNA expression in primary (10) and metastatic WT (6) and in healthy kidney specimens (10) using formalin-fixed, paraffin-embedded (FFPE) samples. miRNA was extracted from FFPE samples using miRNeasy FFPE Kits by Qiagen. Following reverse transcription, cDNA was amplified using miRCURY LNA miRNA Focus PCR Panels by Qiagen, which included primers against 84 specific miRNA targets, of which 81 were successfully amplified. Expression in metastatic WT was compared with primary tumors and healthy kidney tissue. RESULTS Differential expression was particularly evident for 5 miRNAs (miR-17-3p, miR-34b-3p, miR-34c-5p, miR-375-3p, miR-616-3p). Our findings regarding the miR-34 family seem noteworthy in light of the limited existing literature, which similarly reports elevated expression of these miRNAs in WT, although they are more commonly downregulated in many other cancer types. CONCLUSIONS While the sample size in this study was modest, our findings suggest that metastatic tumors exhibit distinct miRNA expression patterns, which may have value for identifying tumors at risk of metastasis. We encourage further studies to validate or refute the role of the miRNAs proposed here in the development of metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.